在Sjögren病中发现了新的自身抗体
Alaa Elsaghir1, Torsten Witte2
1Klinik für Rheumatologie und Immunologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; Department of Microbiology & Immunology, Faculty of Pharmacy, Assiut University, Assiut 71515, Egypt.
Current opinion in immunology
|January 14, 2026
概括
新型自身抗体显示出用于诊断初级Sjögren患者的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 自免疫性疾病 自免疫性疾病
- 生物标志物发现发现
背景情况:
- 初级斯乔格伦病 (SjD) 诊断通常依赖于Ro/SS-A和La/SS-B自身抗体.
- 显著的一小部分SjD患者是血清阴性,需要侵入性活检,并导致诊断延迟.
研究的目的:
- 评估新型自身抗体作为Sjögren病患者的潜在诊断生物标志物,这些患者对Ro / SS-A和La / SS-B自身抗体负面.
- 确定可靠的血清学标记,可以减少对侵入性诊断程序的需求.
主要方法:
- 对研究新型自身抗体在Sjögren病的综合性审查.
- 分析自身抗体点,包括功能性蛋白质和通过蛋白质组阵列识别的自身抗原.
- 评估已识别的自身抗体和面板的诊断敏感性和特异性.
主要成果:
- 虽然一些新型自身抗体 (例如,ASCA,TRIM38) 与Ro/SS-A阳性相关,但另一些则显示出血清阴性SjD的诊断潜力.
- 对肌肉M3受体 (抗M3R) 的自身抗体显示出高灵敏度和特异性.
- 一个12个自身抗原小组显示了54%的灵敏度和100%的特异性;另一个小组获得了46%的灵敏度和95%的特异性,用于血清阴性SjD.
结论:
- 新出现的证据支持新型自身抗体在诊断Ro/SS-A阴性SJD的临床实用性.
- 这些生物标志物有可能改善早期诊断,减少对活检的依赖,并有助于针对性治疗的患者分层.
- 在大型患者队列中进一步验证对于临床整合至关重要.
相关概念视频
Autoimmune Disorders
1.5K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.5K
Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Gastritis-II: Pathophysiology
1.2K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K


